Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and women’s health innovation.
May 2026
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today an update related to: Femasys Expands Fertility Care Portfolio in Europe with CE Mark…
Download official logos, executive headshots, product photography, and company fact sheets. For interview requests or additional materials, contact our media relations team directly.
For urgent media inquiries or to arrange an executive interview, please include your outlet name, story angle, and publication deadline in your email.
Get the latest Femasys updates — from fertility portfolio commercial progress and FemBloc® U.S. trial milestones to educational events and press releases — directly in your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
